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The Department of Public Health’s (DPH) Prescription Drug Monitoring Program (PMP) serves as a repository of data for all prescription drugs dispensed 
statewide, including those prescriptions that are sought after for illicit and non-medical use and thus represent the highest potential for abuse (federal 
Schedules II – V, including certain narcotics, stimulants and sedatives). The PMP also enables prescribers and dispensers to access a patient’s 
prescription history and can be used as a clinical decision-making tool, allowing the provider to have a holistic view of the patient’s medications. 
 
When interpreting PMP county-level data, it is important to emphasize that increases or decreases in a single measure may not indicate an increase or 
decrease in prescription misuse or abuse. Put simply, use does not always equate to abuse. There are many factors that might explain an unusually high 
rate of prescribing in a given area. For instance, an area which contains a large number of residents in long-term care facilities may result a high rate of 
opioid prescribing. 
 
These datasets inform critical discussions about opioid prescribing, provide an important baseline to better inform future policy decisions and allow the 
state and stakeholders to more meaningfully measure whether policy initiatives are effective. 
 
Effective October 6, 2014, all hydrocodone combination drug (HCD) products (e.g., Vicodin) were reclassified from Schedule III to Schedule II.  This 
reclassification during the last quarter of 2014 makes comparisons over time difficult to interpret. Beginning with CY 2015 data, reports of Schedule II 
products will include all HCD prescriptions.  
 
Individuals with activity of concern "thresholds" for this report are based on a 3-month time period. MDPH also releases an annual county-level report 
that provides thresholds that are based on a 12-month time period. Although the numbers (or rates) generated may appear to be comparable, they 
represent different time periods and are NOT an apples-to-apples comparison. The results are only comparable when the thresholds (e.g., 4 different 
providers and 4 different pharmacies), time interval (e.g. over a three-month period), and drug products analyzed (e.g. Schedule II opioids) are the 
same. Meaning, the total number (or rates) of individuals who received Schedule II-V opioid prescriptions from 4 or more providers and had them filled 
at 4 or more pharmacies in a 3-month period cannot and should not be compared with the total number of individuals (or rates) who received Schedule 
II-V opioid prescriptions from 4 or more providers and had them filled at 4 or more pharmacies in a 12-month period. 
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County                          
(County 
classifications are by 
patient zip code; 
patient state must 
also = MA) 
Census  
Population 
Total 
Schedule II 
Opioid 
Prescriptions 
Total 
Number of 
Schedule II 
Opioid Solid 
Dosage Units 
Individuals 
Receiving 
Schedule II 
Opioid 
Prescription 
% of Individuals 
Receiving 
Schedule II Opioid 
Prescription 
 (of total 
population) 
Individuals 
with 
Activity of 
Concern 
Rate of 
Individuals 
with Activity of 
Concern  
(per 1,000) 
Barnstable 214,276 23,903 1,338,858 10,695 5.0 18 1.7 
Berkshire 126,903 14,352 779,594 6,181 4.9 <5 NR 
Bristol 558,324 69,257 4,221,185 28,799 5.2 17 0.6 
Dukes 17,246 1,493 85,225 764 4.4 <5 NR 
Essex 779,018 69,975 3,840,765 32,222 4.1 27 0.8 
Franklin 70,382 9,401 564,110 3,776 5.4 <5 NR 
Hampden 468,467 58,373 3,401,834 24,641 5.3 26 1.1 
Hampshire 161,816 16,316 1,034,172 6,667 4.1 8 1.2 
Middlesex 1,589,774 98,864 5,308,619 49,232 3.1 36 0.7 
Nantucket 11,008 1,000 40,585 492 4.5 <5 NR 
Norfolk 697,181 52,858 3,017,366 25,500 3.7 31 1.2 
Plymouth 513,565 51,261 3,038,903 23,497 4.6 20 0.9 
Suffolk 784,230 47,243 2,837,697 21,937 2.8 31 1.4 
Worcester 819,589 79,203 5,011,873 34,919 4.3 35 1.0 
MA 6,811,779 593,499 34,520,784 269,322 4.0 249 0.9 
Note 1: Individuals with activity of concern "thresholds" for this report are based ONLY on a 3-month time period; see notes on previous page; CY17-Q4 
Note 2: Counts greater than 0 but less than 5 are not reported.  Rates based on these small values also are not reported (NR). 
Note 3: Rates of individuals with activity of concern are based on the population of individuals who have received one or more Schedule II opioid prescriptions during the specified time 
period. 
Note 4: Totals for all counties combined will differ slightly compared to the state totals presented elsewhere because some prescription records could not be assigned a county due to 
inaccurate zip code/city town information reported to the program. 
Note 5: The total sum for the "Number of Individuals Receiving Schedule II Opioid Prescription" will be slightly different than the sum presented for the state in Figure 2 due to a small 
number of double counting of individuals moving from one county to another during the specified time period. 
Note 6: PMP data are preliminary and subject to updates. The MA PMP database is continuously updated to allow for prescription record correction data submitted by pharmacies. This 
data were extracted on 1/11/2018; Release Date: February 2018. 
Note 7: Beginning in 3rd quarter of 2016 the Department of Veteran's Affairs (VA) facilities began submitting data to the MA PMP. 
Note 8: National Center for Health Statistics.  Postcensal estimates of the resident population of the United States for July 1, 2010-July 1, 2016,  
by year, county, single-year of age (0, 1, 2, .., 85 years and over), bridged race, Hispanic origin, and sex (Vintage 2016).       
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MA Prescription Monitoring Program Data 
Trend Analyses for Schedule II Opioids Only 
 
 Registered MassPAT providers conducted over 1.5 million searches in the 4th Quarter of 2017; there was an increase of approximately 35,000 
searches from the previous quarter.   
 In the 4th Quarter of 2017 there were just under 594,000 Schedule II opioid prescriptions reported to the MA PMP; this is a small decrease from the 
previous quarter and approximately a 30% decrease from the 1st Quarter of 2015 (n = 841,990 Schedule II opioid prescriptions). 
                            
Note: PMP data are subject to updates. The MA PMP database is continuously updated to allow for prescription record correction data submitted by 
pharmacies. The data for the quarterly trends were extracted on 1/12/2018. 
 
 Just under 268,000 individuals in MA received prescriptions for Schedule II opioids in the 4th Quarter of 2017; this is a small decrease from the 
previous quarter and over a 30% decrease from the 1st Quarter of 2015 (n = 390,532). 
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Note: PMP data are subject to updates. The MA PMP database is continuously updated to allow for prescription record correction data submitted by 
pharmacies. The data for the quarterly trends were extracted on 1/12/2018. 
 
 The rate of individuals with activity of concern (also referred to as multiple provider episodes) decreased from 14.3 to 6.3 per 1,000 individuals 
between CY 2013 and CY 2017, a 56% reduction in activity of concern. 
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Note: PMP data are subject to updates. The MA PMP database is continuously updated to allow for prescription record correction data submitted by 
pharmacies. The data for CY 2017 were extracted on 01/12/2018.       
